Eurofins Scientific SE (ERF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eurofins Scientific SE (ERF) has a cash flow conversion efficiency ratio of 0.220x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€789.60 Million ≈ $923.13 Million USD) by net assets (€3.59 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ERF days of operational coverage to measure how many days the company can operate on defensive assets alone.
Eurofins Scientific SE - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tubize-Fin
BR:TUB
|
-0.001x |
|
The AES Corporation
NYSE:AES
|
0.128x |
|
Leader Harmonious Drive Systems Co Ltd
SHG:688017
|
0.022x |
|
Erie Indemnity Company
NASDAQ:ERIE
|
0.039x |
|
REC Limited
NSE:RECLTD
|
-0.035x |
|
Cognex Corporation
NASDAQ:CGNX
|
0.030x |
|
BALOISE HLDG AG ADR/1/10
F:BLO
|
N/A |
|
Goldenmax International Technology Ltd
SHE:002636
|
-0.025x |
Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ERF stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.59 Billion ≈ $4.19 Billion |
€1.29 Billion ≈ $1.51 Billion |
0.361x | +47.44% |
| 2024-12-31 | €5.38 Billion ≈ $6.30 Billion |
€1.32 Billion ≈ $1.54 Billion |
0.245x | +23.62% |
| 2023-12-31 | €5.14 Billion ≈ $6.01 Billion |
€1.02 Billion ≈ $1.19 Billion |
0.198x | -15.41% |
| 2022-12-31 | €4.85 Billion ≈ $5.67 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.234x | -27.44% |
| 2021-12-31 | €4.68 Billion ≈ $5.47 Billion |
€1.51 Billion ≈ $1.77 Billion |
0.323x | -1.95% |
| 2020-12-31 | €3.72 Billion ≈ $4.34 Billion |
€1.22 Billion ≈ $1.43 Billion |
0.329x | +40.74% |
| 2019-12-31 | €2.90 Billion ≈ $3.39 Billion |
€677.90 Million ≈ $792.54 Million |
0.234x | +17.07% |
| 2018-12-31 | €2.72 Billion ≈ $3.18 Billion |
€543.89 Million ≈ $635.87 Million |
0.200x | +22.41% |
| 2017-12-31 | €2.48 Billion ≈ $2.90 Billion |
€405.12 Million ≈ $473.63 Million |
0.163x | -22.89% |
| 2016-12-31 | €1.76 Billion ≈ $2.05 Billion |
€371.84 Million ≈ $434.72 Million |
0.212x | -21.46% |
| 2015-12-31 | €1.08 Billion ≈ $1.26 Billion |
€291.15 Million ≈ $340.38 Million |
0.270x | -15.63% |
| 2014-12-31 | €664.24 Million ≈ $776.57 Million |
€212.17 Million ≈ $248.05 Million |
0.319x | -25.54% |
| 2013-12-31 | €394.74 Million ≈ $461.49 Million |
€169.34 Million ≈ $197.97 Million |
0.429x | +20.27% |
| 2012-12-31 | €376.12 Million ≈ $439.73 Million |
€134.16 Million ≈ $156.85 Million |
0.357x | +3.57% |
| 2011-12-31 | €320.31 Million ≈ $374.48 Million |
€110.32 Million ≈ $128.98 Million |
0.344x | -6.46% |
| 2010-12-31 | €230.69 Million ≈ $269.70 Million |
€84.94 Million ≈ $99.30 Million |
0.368x | +16.19% |
| 2009-12-31 | €203.03 Million ≈ $237.37 Million |
€64.34 Million ≈ $75.22 Million |
0.317x | +15.65% |
| 2008-12-31 | €219.12 Million ≈ $256.17 Million |
€60.04 Million ≈ $70.19 Million |
0.274x | +49.26% |
| 2007-12-31 | €215.56 Million ≈ $252.02 Million |
€39.57 Million ≈ $46.26 Million |
0.184x | -37.57% |
| 2006-12-31 | €102.64 Million ≈ $119.99 Million |
€30.18 Million ≈ $35.28 Million |
0.294x | -4.93% |
| 2005-12-31 | €82.42 Million ≈ $96.35 Million |
€25.49 Million ≈ $29.80 Million |
0.309x | -12.53% |
| 2004-12-31 | €66.10 Million ≈ $77.28 Million |
€23.37 Million ≈ $27.32 Million |
0.354x | +44.47% |
| 2003-12-31 | €53.85 Million ≈ $62.96 Million |
€13.18 Million ≈ $15.41 Million |
0.245x | +12.56% |
| 2002-12-31 | €52.91 Million ≈ $61.86 Million |
€11.51 Million ≈ $13.45 Million |
0.217x | -- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more